EMILY CIALONE: Open Payments
NPI 1457117889 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 30 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $63 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $97 |
| Alnylam Pharmaceuticals Inc. | 5 | $91 |
| Merck Sharp & Dohme LLC | 4 | $81 |
| PFIZER INC. | 2 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| BridgeBio Pharma, Inc. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Lilly USA, LLC | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: SYMPLICITY G3, AMVUTTRA, VERQUVO, Kerendia, Attruby, VYNDAQEL, Veozah, ELIQUIS.
Industry payments across MS — which companies pay providers there.
